EPS Diluted (Annual) Chart

Historical EPS Diluted (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 -5.305
December 31, 2024 -2.994
December 31, 2023 4.144
December 31, 2022 39.69
December 31, 2021 46.84
Date Value
December 31, 2020 0.0697
December 31, 2019 -0.9476
December 31, 2018 -5.344
December 31, 2017 -10.43

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -79.07
Moderna, Inc. -7.254
Mereo BioPharma Group Plc -0.2633
NuCana Plc -17.20
Immatics NV -1.812